V-Square Quantitative Management’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.27M Sell
14,020
-385
-3% -$32.3K 0.12% 146
2026
Q1
$1.15M Buy
14,405
+37
+0.3% +$3.05K 0.12% 150
2025
Q4
$1.22M Sell
14,368
-1,643
-10% -$135K 0.13% 134
2025
Q3
$1.25M Buy
16,011
+691
+5% +$54K 0.21% 90
2025
Q2
$1.2M Sell
15,320
-311
-2% -$23.2K 0.16% 124
2025
Q1
$1.13M Buy
15,631
+257
+2% +$18.4K 0.17% 129
2024
Q4
$1.14M Buy
15,374
+348
+2% +$24.4K 0.16% 129
2024
Q3
$992K Buy
15,026
+1,437
+11% +$104K 0.15% 137
2024
Q2
$1.26M Buy
13,589
+94
+0.7% +$8.32K 0.2% 88
2024
Q1
$1.29M Buy
13,495
+2,448
+22% +$206K 0.18% 88
2023
Q4
$842K Buy
11,047
+2,652
+32% +$185K 0.15% 107
2023
Q3
$582K Buy
8,395
+2,863
+52% +$230K 0.26% 71
2023
Q2
$522K Sell
5,532
-199
-3% -$17.3K 0.38% 58
2023
Q1
$474K Buy
+5,731
New +$450K 0.44% 58

Other funds holding EW

V-Square Quantitative Management's EW Position: Q2 2026 in Review

V-Square Quantitative Management reduced its Edwards Lifesciences (EW) stake by 2.7% in Q2 2026, selling an estimated $32.3K and leaving 14,020 shares worth $1.27M. The position accounts for 0.12% of the portfolio, ranked #146.

V-Square Quantitative Management first reported a position in EW in Q1 2023 and has held it in 14 quarters since. The position peaked at $1.29M in Q1 2024. 505 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • V-Square Quantitative Management held 14,020 shares of Edwards Lifesciences worth $1.27M as of Q2 2026.
  • V-Square Quantitative Management sold 385 Edwards Lifesciences shares in Q2 2026, an estimated $32.3K.
  • Edwards Lifesciences made up 0.12% of V-Square Quantitative Management's portfolio in Q2 2026, its #146 holding.
  • V-Square Quantitative Management first reported a position in Edwards Lifesciences in Q1 2023 and has held it in 14 quarters since.
  • V-Square Quantitative Management's Edwards Lifesciences position peaked at $1.29M in Q1 2024.
  • 505 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on V-Square Quantitative Management's 13F filing for Q2 2026, filed 27 Jul 2026.